Home/Filings/4/0001628280-26-000194
4//SEC Filing

ASHKEN IAN G H 4

Accession 0001628280-26-000194

CIK 0001796209other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:56 PM ET

Size

16.9 KB

Accession

0001628280-26-000194

Insider Transaction Report

Form 4
Period: 2025-12-31
Transactions
  • Award

    Common Stock

    2025-12-31+2,913,5652,918,648 total(indirect: By LLC)
  • Other

    Common Stock

    2026-01-02$38.97/sh9,979$388,8822,908,669 total(indirect: By LLC)
  • Other

    Common Stock

    2026-01-022,893,11715,552 total(indirect: By LLC)
  • Other

    Common Stock

    2026-01-02+2,893,11710,861,284 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By Trust)
    53,730
  • Common Stock

    (indirect: See footnote)
    300,000
  • Restricted Stock Units

    Common Stock (4,740 underlying)
    4,740
  • Series A Preferred Stock

    (indirect: By LLC)
    Common Stock (1,152,000 underlying)
    1,152,000
Footnotes (10)
  • [F1]Represents a stock dividend on shares of Series A Preferred Stock of the Issuer. The holder of Series A Preferred Stock of the Issuer is entitled to receive an annual stock dividend based on the market price of the Issuer's Common Stock for the last ten days of the calendar year.
  • [F10]The Series A Preferred Stock is convertible at any time at the election of the holder, on a one-for-one basis, into shares of Common Stock for no additional consideration. The Series A Preferred Stock shall automatically convert into Common Stock on the last day of the seventh full financial year of the Issuer following October 1, 2019 (or if such date is not a trading day, the first trading day immediately following such date).
  • [F2]The shares of Common Stock (prior to the transactions described in footnotes 3 and 4) and Series A Preferred Stock are held directly by Mariposa Acquisition IV, LLC. The Nancy and Ian Ashken Investment Trust LLLP (the "Ashken Investment Trust"), the general partner of which is wholly-owned by The Ian G.H. Ashken Living Trust (the "Ashken Trust"), of which Mr. Ashken is the trustee and beneficiary, holds a limited liability company interest in Mariposa Acquisition IV, LLC and, as a result, may be deemed to have a pecuniary interest in 2,918,648 shares of Common Stock (prior to the transactions described in footnotes 3 and 4) and 1,152,000 shares of Series A Preferred Stock held by Mariposa Acquisition IV, LLC. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
  • [F3]Represents a transfer to employees of an affiliate of Mariposa Acquisition IV, LLC for services provided.
  • [F4]Represents a pro rata distribution from Mariposa Acquisition IV, LLC to the Ashken Investment Trust.
  • [F5]The shares of Common Stock reported herein are held directly by the Ashken Investment Trust, the general partner of which is wholly-owned by the Ashken Trust, of which Mr. Ashken is the trustee and beneficiary. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
  • [F6]The shares of Common Stock reported herein are held directly by the Ashken Trust, of which Mr. Ashken is the trustee and beneficiary. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
  • [F7]Held jointly in an account by the Ashken Trust and the Nancy K. Ashken Living Trust.
  • [F8]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F9]These restricted stock units vest on May 16, 2026, which is the one-year anniversary of the grant date, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.

Issuer

APi Group Corp

CIK 0001796209

Entity typeother

Related Parties

1
  • filerCIK 0001093725

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:56 PM ET
Size
16.9 KB